Skip to main content
. Author manuscript; available in PMC: 2021 Oct 5.
Published in final edited form as: Circ Cardiovasc Interv. 2017 Sep;10(9):e004981. doi: 10.1161/CIRCINTERVENTIONS.117.004981

Table 1.

Baseline Characteristics of Patients Discharged on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Compared Across Baseline WBC Tertiles

WBC Tertile 1 (2.1–7.1 ×103 cells/μL; n=1469) WBC Tertile 2 (7.11–9.1×103 cells/μL; n=1353) WBC Tertile 3 (9.11–29.0× 103 cells/μL; n=1400) Ptrend Value
Age, y 65.4±10.6 64.1±11.0 61.8±11.9 <0.001
Male sex (%) 73.8 74.4 75.6 0.28
Body mass index, kg/m2 29.0±5.4 29.6±5.7 29.2±5.9 0.27
Medical history (%)
 Dyslipidemia 80.0 78.1 68.1 <0.001
 Hypertension 84.8 81.7 75.1 <0.001
 Diabetes mellitus 35.3 34.7 30.6 0.01
 Prior coronary artery disease (MI, PCI, or CABG) 54.7 49.8 38.8 <0.001
 Stroke 3.2 3.3 3.3 0.90
 Peripheral vascular disease 6.5 7.2 7.5 0.28
Tobacco use (%) 11.4 17.7 31.0 <0.001
Medications (%)
 Aspirin 78.4 73.5 58.6 <0.001
 Thienopyridine 50.6 41.9 32.0 <0.001
 Glycoprotein IIb/IIIa inhibitor use 11.1 14.5 19.9 <0.001
Cardiac status at admission (%)
 Acute coronary syndrome 32.6 38.7 56.9 <0.001

Continuous data presented as mean±SD. CABG indicates coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous coronary intervention with stent placement; and WBC, white blood cell.